Our services
Our services are tailored to the needs of each client and engagement. We work across three channels — pharmaceutical companies, healthcare payers, and clinical departments — and at every stage of the evidence lifecycle.

For pharma partners, typical engagements range from early characterisation of target populations and unmet need, through support for TLV and HTA submissions, to post-launch effectiveness programmes and peer-reviewed publication. We design and execute studies end-to-end: protocol development, data access and analytical frameworks creation, analysis, and delivery of publication-ready outputs.

For payers and regional formulary bodies, we provide the evidence infrastructure that makes conditional access credible: pre-specified analyses designed to answer the questions that reimbursement decisions depend on.

For clinical departments, we offer structured kvalitetsuppföljning — rigorous analysis of a department's own patient population benchmarked against guidelines, designed to surface variation and support evidence-based improvement in care.

Our principles
Our mission is to generate rigorous, independent scientific evidence that advances healthcare decisions — for patients, clinicians, payers, and the pharmaceutical industry.

We are certified to ISO/IEC 27001 (Information Security Management), subscribe to the ENCePP Code of Conduct, and follow the ISPE Guidelines for Good Pharmacoepidemiology Practices.

We are actively engaged in the development of methods and analytical frameworks for comparative effectiveness research — publishing not only study results but the methodological boundaries of the approaches we use.